FDA Add Safety Warnings To Rheumatoid Arthritis Drugs

September 5, 2008

Washington (ChattahBox) - The U.S. Food and Drug Administration (FDA) has added new black box warnings to four popular prescription drugs used to treat rheumatoid arthritis, Crohn’s disease, and other conditions.

The FDA released these new black box warnings after the drugs have been linked in sever instances to fatal fungal infections.

The drugs, including Humira, Remicade, Cimzia, and Enbrel, ease the pain of arthritis. They do so though by suppressing the human immune system, making it easier to pick up infections.

The FDA has added the new black box warnings on their Web site, and will hopefully help make patients aware of the risks.

Around the world to this point, there have been 240 instances where patients suffered potentially fatal fungal infections from the drugs.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.